A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity
暂无分享,去创建一个
Y. Belkaid | G. Milon | D. Sacks | R. Lira | S. Mendez | N. Kadambi
[1] T. Theander,et al. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. , 1999, Clinical immunology.
[2] A. Stagg,et al. Murine dendritic cells internalize Leishmania major promastigotes, produce IL‐12 p40 and stimulate primary T cell proliferation in vitro , 1999, European journal of immunology.
[3] W. Paul,et al. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. , 1999, Journal of immunology.
[4] N. Glaichenhaus,et al. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites , 1999, European journal of immunology.
[5] M. Roncarolo,et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.
[6] G. Feng,et al. Regulation of macrophage IL‐12 synthesis by Leishmania phosphoglycans , 1999, European journal of immunology.
[7] Y. Belkaid,et al. Development of a Natural Model of Cutaneous Leishmaniasis: Powerful Effects of Vector Saliva and Saliva Preexposure on the Long-Term Outcome of Leishmania major Infection in the Mouse Ear Dermis , 1998, The Journal of experimental medicine.
[8] Yasmine Belkaid,et al. Uptake of Leishmania major Amastigotes Results in Activation and Interleukin 12 Release from Murine Skin–derived Dendritic Cells: Implications for the Initiation of Anti-Leishmania Immunity , 1998, The Journal of experimental medicine.
[9] Yasmine Belkaid,et al. Analysis of cytokine production by inflammatory mouse macrophages at the single‐cell level: selective impairment of IL‐12 induction in Leishmania ‐infected cells , 1998, European journal of immunology.
[10] Elio Cenci,et al. Endogenous Interleukin 4 Is Required for Development of Protective Cd4 Ϩ T Helper Type 1 Cell Responses to Candida Albicans , 1998 .
[11] P. Kaye,et al. Dendritic cells, but not macrophages, produce IL‐12 immediately following Leishmania donovani infection , 1998, European journal of immunology.
[12] J. Shaw,et al. Experimental cutaneous leishmaniasis. IV. The humoral response of Cebus apella (Primates: Cebidae) to infections of Leishmania (Leishmania) amazonensis, L. (Viannia) lainsoni and L. (V.) braziliensis using the direct agglutination test. , 1997, Acta tropica.
[13] G. Trinchieri,et al. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. , 1997, Journal of immunology.
[14] J. Sun,et al. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. , 1997, Journal of immunology.
[15] P. Bergstresser,et al. Cytokine-mediated communication by keratinocytes and Langerhans cells with dendritic epidermal T cells. , 1996, Seminars in immunology.
[16] D. Mcmahon-Pratt,et al. Leishmania‐infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells , 1996, European journal of immunology.
[17] H. Bluethmann,et al. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response. , 1996, Immunobiology.
[18] C. Bogdan,et al. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase , 1996, The Journal of experimental medicine.
[19] S. Reed,et al. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. , 1996, Immunity.
[20] C. Roberts,et al. Different roles for interleukin-4 during the course of Toxoplasma gondii infection , 1996, Infection and immunity.
[21] T. Horii,et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. , 1996, Immunity.
[22] R. Badolato,et al. Promastigotes Selectively Inhibit Interleukin 12 Induction in Bone Marrow-derived Macrophages from Susceptible and Resistant Mice , 1996 .
[23] Y. Belkaid,et al. A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. , 1996, Journal of immunological methods.
[24] H. Macdonald,et al. In susceptible mice, Leishmania major induce very rapid interleukin‐4 production by CD4+ T cells which are NK1.1− , 1995, European journal of immunology.
[25] N. Ganguly,et al. Macrophage‐T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania‐infected macrophages and its implication in the suppression of cell‐mediated immunity , 1995, European journal of immunology.
[26] M. Belosevic,et al. Response of scid mice to establishment of Leishmania major infection , 1995, Clinical and experimental immunology.
[27] L. Glimcher,et al. Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. , 1995, The Journal of infectious diseases.
[28] T. Theander,et al. The pathology of cutaneous leishmaniasis due to Leishmania major in Sudan. , 1995, The American journal of tropical medicine and hygiene.
[29] P. Scott,et al. The role of the innate immune response in Th1 cell development following Leishmania major infection , 1995, Journal of leukocyte biology.
[30] M. Röllinghoff,et al. Dendritic cells in Leishmania major‐immune mice harbor persistent parasites and mediate an antigen‐specific T cell immune response , 1995, European journal of immunology.
[31] T. Theander,et al. Antigen‐presenting cells in human cutaneous leishmaniasis due to Leishmania major , 1995, Clinical and experimental immunology.
[32] P. Kaye,et al. Deficient expression of co‐stimulatory molecules on Leishmania‐infected macrophages , 1994, European journal of immunology.
[33] C. Bogdan,et al. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major , 1994, The Journal of experimental medicine.
[34] G. Trinchieri,et al. Infection with Leishmania major induces interleukin-12 production in vivo. , 1994, Immunology letters.
[35] R. Locksley,et al. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection , 1994, The Journal of experimental medicine.
[36] J. Guillet,et al. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. , 1993, Journal of immunology.
[37] M. Röllinghoff,et al. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cells , 1993, European journal of immunology.
[38] R. Schaub,et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.
[39] R. Rerko,et al. Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.
[40] E. Handman,et al. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host , 1993, Infection and immunity.
[41] A. Kelso,et al. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. , 1992, Journal of immunology.
[42] M. Röllinghoff,et al. Murine epidermal Langerhans cells are potent stimulators of an antigen‐specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis , 1992, European journal of immunology.
[43] R. Coffman,et al. IL-4 induces a Th2 response in Leishmania major-infected mice. , 1992, Journal of immunology.
[44] M. Belosevic,et al. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. , 1989, Journal of immunology.
[45] N. Reiner,et al. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. , 1987, Journal of immunology.
[46] R. Pearson,et al. Early histopathology of experimental infection with Leishmania donovani in hamsters. , 1987, The Journal of parasitology.
[47] Y. Schlein,et al. The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. , 1986, The American journal of tropical medicine and hygiene.
[48] T. Boon,et al. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.
[49] J. Convit,et al. In situ characterization of the cellular immune response in American cutaneous leishmaniasis. , 1985, Clinical and experimental immunology.
[50] J. O. Hill. Resistance to cutaneous leishmaniasis: acquired ability of the host to kill parasites at the site of infection , 1984, Infection and immunity.
[51] R. Locksley,et al. Development of cellular immunity in cutaneous leishmaniasis due to Leishmania tropica. , 1984, The Journal of infectious diseases.
[52] R. North,et al. Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis , 1983, Infection and immunity.
[53] C. Hale,et al. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. , 1982, Journal of immunology.
[54] H. Rey. Cellular Reactions in the Dermal Connective Tissue of the Hamster to Leishmania brasiliensis. , 1943 .
[55] C. Bogdan,et al. Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite , 1998 .
[56] H. Moll,et al. Dendritic cells seclude Leishmania parasites that persist in cured mice--a role in the maintenance of T-cell memory? , 1995, Advances in experimental medicine and biology.
[57] P. Vassalli,et al. Involvement of specific Lyt‐2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis , 1987, European journal of immunology.
[58] D. Dumonde,et al. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. , 1976, Clinical and experimental immunology.